Skip to content

Effect of Sleep Disorder on the Development of Lung Tumors

Effect of Sleep Disorder on the Development of Lung Tumors, a Perspective, Single-centered Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05745506
Enrollment
200
Registered
2023-02-27
Start date
2023-02-28
Completion date
2026-12-31
Last updated
2023-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorder, Lung Tumor

Brief summary

The goal of this observational study is to observe the lung tumor development in lung tumor patients with long-term sleep disorder. The main questions it aims to answer are: * will long-term sleep disorder promote the malignancy of lung tumor * if so, how exactly will the microenvironment of lung tumor change Participants will receive PSQI scale and MRI functional brain imaging before surgery, blood and tumor tissue will be collected during the surgery. Researchers will set non-sleep disorder group as control group to see if lung tumor microenvironment change when long-term sleep disorder exists in lung tumor patiens.

Interventions

None listed

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* 18-75 years old * elective sublobectomy for primary lung tumor * ASA grade I-II * Informed consent of the patient or family

Exclusion criteria

* Combination of serious heart, liver, kidney, central nervous system, blood system, immune system diseases or serious mental illness * Combination of other cancers * untreated active lung infection * patients with preoperative neoadjuvant radiotherapy

Design outcomes

Primary

MeasureTime frameDescription
tumor microenvironment in sleep-disordered lung cancer patients3 months after surgerywe use single cell sequencing to analyze microenvironment alterations of tumor tissues in enrolled patients.

Secondary

MeasureTime frameDescription
peripheral blood levels of neurotransmitters in sleep-disordered lung cancer patients3 months after surgeryperipheral blood levels of epinephrine, noradrenaline, 5-HT in sleep-disordered lung cancer patients
Functional brain imaging in sleep-disordered lung cancer patients3 months after surgeryFunctional brain imaging

Contacts

Primary ContactWeifeng Yu
ywf808@yeah.net13901961704
Backup ContactYumiao Shi
shiyumiaoxka@163.com19821850236

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026